Psychiatry - DelRicht Research

Psychiatry

Psychiatry Sites Nationwide

Advancing Psychiatry Research

At DelRicht Research, we have a specialized network of sites focused on psychiatry, offering unrivaled patient access and investigator support for your research programs. Our commitment to advancing psychiatry research is reflected in our partnerships with leading physicians and healthcare facilities.

Therapeutic Expertise

Our expertise in psychiatry research includes, but is not limited to:

  • Mood Disorders: Major Depressive Disorder (MDD), Treatment-Resistant Depression (TRD), Bipolar Disorder, Bipolar Depression
  • Anxiety Disorders: Generalized Anxiety Disorder (GAD), Social Anxiety Disorder, Post-traumatic Stress Disorder (PTSD)
  • Agitation & Behavioral: Schizophrenia, Acute Agitation in Bipolar Disorder, Agitation Associated with Alzheimer’s Disease
  • Neurodevelopmental: Adult and Childhood ADHD, Autism Spectrum Disorder (Behavioral Symptom Targets)
  • Psychedelic: Psychedelic-Assisted Therapy (LSD, Psilocybin Analogs)
  • Addiction & Substance Use Disorders: Alcohol Use Disorder (AUD), Substance Abuse Disorders 

x4 Sites Recognized as Top Enroller Status

x1 First Patient Screened or Enrolled

Capabilities

DelRicht Research’s broad network provides access to diverse psychiatry patients and supports high-quality studies with experienced physicians and staff. Key capabilities include:

  • DEA License and CDS Registration
  • Secure Investigational Product Storage (Including Controlled Substances) 
  • Simulated Home Environment Treatment Rooms
  • Audio/Visual Monitored Treatment Rooms
  • Infusion-Experienced Staff
  • Studies on Cognitive Behavioral Therapy
  • Substance Abuse Treatment Programs
  • Digital and Telepsychiatry Interventions
  • Audio/Visual Monitored Investigational Product Storage Rooms
  • Security Cloud Backup Storage for Security Cameras within IP Storage and Treatment Rooms
  • ​​Structured Psychiatric Diagnostic Interviews (e.g., MINI, SCID)
  • Experienced Staff Trained on Validated Psychiatric Rating Scales (MADRS, HAM-D, YMRS, PANSS, CGI-S/I)
  • Cognitive Testing (MoCA, RBANS, MMSE)
  • Long-Acting Injectable Administration (Antipsychotics, Antidepressants)
  • Inpatient and Outpatient Trial Management
  • Central Rater and Remote Assessment Coordination
  • Patient-Reported Outcomes via ePRO and EMA Platforms
  • Suicide Risk Monitoring and Safety Protocols (C-SSRS)
  • Substance Use and Dependence Trial Experience (Alcohol, Cannabis, Opioid)
  • Tracking System to Monitor Medical Equipment, Location, Calibration, Usage, and Maintenance
  • Training Tracking System to Monitor Study Staff and Site Certifications and Licensure

6 Psychiatry Principal Investigators

90+ Years of Collective PI Experience

Meet Some Of Our Investigators

Caroline Campion, MD

Board Certified, Psychiatry

Jay Italiya, MD

Board Certified, Psychiatry

Patrice Mann, MD

Board Certified, Psychiatry

Case Studies & Trial Highlights

Enrolled 467%

in a Phase 3 Major Depressive Disorder (MDD) Trial

First Site

Activated and 2nd Patient Screened in a Phase 4 MDD Trial

Enrolled 183%

in a Phase 4 ADHD Trial for Children Ages 4-12

Psychiatry

Site Network of Choice

See Our Psychiatry Locations

Let's talk about your next trial.